Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Transfusion Clinique et Biologique
- Vol. 10 (3) , 165-169
- https://doi.org/10.1016/s1246-7820(03)00035-1
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune GlobulinNew England Journal of Medicine, 2001
- Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc ReceptorScience, 2001
- Mechanism of Intravenous Immune Globulin Therapy in Antibody-Mediated Autoimmune DiseasesNew England Journal of Medicine, 1999
- Modulation of Endothelial Cell Function by Normal Polyspecific Human Intravenous ImmunoglobulinsThe American Journal of Pathology, 1998
- FcRECEPTOR BIOLOGYAnnual Review of Immunology, 1997
- High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.Journal of Clinical Investigation, 1994
- Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpuraThe Lancet, 1993
- Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor AntibodyNew England Journal of Medicine, 1986
- EFFECT OF INTRAVENOUS IMMUNOGLOBULIN IN IMMUNE THROMBOCYTOPENIA: Competitive Inhibition of Reticuloendothelial System Function by Sequestration of Autologous Red Blood Cells?The Lancet, 1983
- Transient Reversal of Thrombocytopenia in Idiopathic Thrombocytopenic Purpura by High-Dose Intravenous Gamma GlobulinNew England Journal of Medicine, 1982